The Cell Expansion Market value was USD 17.4 billion in 2022 and is expected to increase to USD 66.17 billion by 2032, registering a revenue CAGR of 16% during the forecast period. Factors such as the increasing prevalence of genetic and chronic diseases, rising demand for cell-based therapeutics and regenerative medicine, and increasing funding for cell-based research are driving the growth of the market.
Cell expansion is a crucial process in cell-based research, drug development, and therapeutic applications, involving a variety of growth factors, cytokines, and medium to promote cell growth and proliferation in vitro. The demand for cell expansion technologies is rising, particularly in the biopharmaceutical sector, due to the development of vaccines, antibodies, and cell treatments.
Get a free sample PDF of the report, visit @
https://www.reportsanddata.com/download-free-sample/6336
The rising prevalence of chronic diseases, such as diabetes, cancer, and cardiovascular illnesses, is one of the key factors driving revenue growth of the market. The need for cell-based therapies to treat these disorders is increasing, as is the demand for cell expansion technology due to developments in gene editing and gene therapy.
Key players in the Cell Expansion Market:
- Thermo Fisher Scientific, Inc.
- Merck KGaA
- Becton, Dickinson and Company
- Danaher Corporation
- Lonza Group AG
- Corning Incorporated
- Eppendorf AG
- Miltenyi Biotec GmbH
- Stemcell Technologies Inc.
- Terumo BCT, Inc.
The need for cell-based therapies and regenerative medicine is another major factor driving revenue growth of the market. Cell-based therapies are used in the rapidly developing field of regenerative medicine to replace, restore, or regenerate damaged tissues and organs. The aging population and rising prevalence of chronic disease are driving demand for regenerative medicine.
To know more about the latest insights of the report, visit @
https://www.reportsanddata.com/request-latest-insight/6336
Increased financing for cell-based research is driving revenue growth of the market. Governments and commercial groups are extensively funding cell-based research for creating novel treatments for various ailments. Technological developments in cell expansion systems are also driving revenue growth of the market, with businesses creating cutting-edge techniques that are more effective, affordable, and scalable.
However, factors such as the high cost of cell multiplication systems, lesser availability of qualified specialists, and moral concerns about the use of embryonic stem cells are hampering revenue growth of the market. In addition, the regulatory framework for cell-based therapies is complicated and differs across different geographic areas.
The global cell expansion market is segmented into human cells and animal cells based on application. The human cells segment is expected to account for the largest revenue share during the forecast period. The biopharmaceutical segment is expected to register the fastest revenue CAGR during the forecast period. The global cell expansion market is also segmented into cancer and cell-based research, regenerative medicine, and other applications, with the cell-based research segment expected to account for the largest revenue share.
In conclusion, the increasing prevalence of chronic diseases, rising need for cell-based therapies and regenerative medicine, increasing funding for cell-based research, and technological developments in cell expansion systems are driving the growth of the global cell expansion market. However, the high cost of cell multiplication systems, lesser availability of qualified specialists, and moral concerns about the use of embryonic stem cells are hampering revenue growth of the market.
Request customization of the report @
https://www.reportsanddata.com/request-customization-form/6336
Thank you for reading our report. Please connect with us to know more about the report and its customization feature. Our team will ensure the report is well suited to meet your requirements.
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behaviour shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact:
John W, Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs
Browse for more reports…
